Pharmaco - Press Releases

Date	Title	Company
18-Dec-2019	Vaccitech Oncology Limited enters collaboration with Cancer Research UK to fund a Phase I/IIa clinical trial as first-line NSCLC therapy	Vaccitech Ltd
18-Dec-2019	Sartorius Establishes Scientific Advisory Board	B3C newswire
18-Dec-2019	Sartorius Establishes Scientific Advisory Board	B3C newswire
18-Dec-2019	MC2 Therapeutics Announces Positive Top-line Results from EU Phase 3 Head-to-Head Trial Comparing Wynzora™ Cream to Daivobet® Gel in Patients with Psoriasis	B3C newswire
18-Dec-2019	MC2 Therapeutics Announces Positive Top-line Results from EU Phase 3 Head-to-Head Trial Comparing Wynzora™ Cream to Daivobet® Gel in Patients with Psoriasis	B3C newswire
18-Dec-2019	Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO	Pathios Therapeutics
18-Dec-2019	Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy	B3C newswire
18-Dec-2019	Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy	B3C newswire
18-Dec-2019	BC Platforms Closes $15 Million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics	B3C newswire
18-Dec-2019	Douglas reports excellent growth in fiscal 2018/19	Douglas GmbH
18-Dec-2019	BC Platforms Closes $15 Million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics	B3C newswire
18-Dec-2019	EVOTEC EXPANDS SERVICE AGREEMENT WITH SANOFI TO CREATE A CENTRALISED GLOBAL SAMPLE MANAGEMENT HUB IN TOULOUSE	Evotec SE
17-Dec-2019	NICE recommends Vifor Pharma’s Veltassa® (patiromer) for adults with hyperkalaemia in England[i]	Vifor Pharma UK
17-Dec-2019	From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria	TECHNICAL UNIVERSITY OF MUNICH
17-Dec-2019	DrFirst's Patent-Pending AI-Based Technology Solves Major Hurdles to Medication Reconciliation: Missing Information and Unstructured Data	DrFirst
17-Dec-2019	ARMGO® Pharma Inc. Announces Clinical Trial of ARM210/S48168 for the Treatment of Ryanodine Receptor Type 1 Related Myopathies	ARMGO Pharma, Inc.
17-Dec-2019	Nektar Therapeutics Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.	Nektar Therapeutics
17-Dec-2019	Immix adds Biotech VC Mesa Verde to Investor Syndicate and Receives IRB Approval to Enroll Patients in Phase 1b/2a Cancer Study in the United States	Immix Biopharma, Inc.
17-Dec-2019	Cellestia Biotech AG Successfully Closes Series B Financing Round, Raising a Total of CHF 20 Million. Guido Guidi Elected New Chairman of the Board of Directors and Robert Karsunky Elected New Chairman of the Audit Committee and Board of Directors Member.	B3C newswire
17-Dec-2019	Cellestia Biotech AG Successfully Closes Series B Financing Round, Raising a Total of CHF 20 Million. Guido Guidi Elected New Chairman of the Board of Directors and Robert Karsunky Elected New Chairman of the Audit Committee and Board of Directors Member.	B3C newswire